207_Combined course Presentations

 5.002 patients treated for HL with supradiaphragmatic RT at age <36 in UK  1956-2003  Median RT dose 36 Gy

 Cumulative risk at 40 years was 48% for patients treated at younger ages with doses >40 Gy  Breast cancer risk was twice as great in patients treated with mantle RT as in those who received different fields of supradiaphragmatic RT

Swerdlow AJ. et al. JCO 2012